Axil Brands (AXIL) Q1 2027 earnings review

Axil's sales fell, but stores ordered its new earbuds

Axil, which sells hearing protection and earbuds, sold less this quarter while it got new earbuds ready. Sales fell from a year ago because the old XCOR model slowed and a large order did not repeat, Axil said. By our math, a one-time refund of import duties turned a small operating loss into a profit. Chief executive Jeff Toghraie said XCOR II orders passed $3.6 million by late September.

At a glance
Revenue$6.1M −11% from a year ago
Operating result, excluding the duty refund−$0.11M +$0.41M a year ago
Cash, with no debt$7.9M $4.5M at the end of May
Second-quarter outlookNo sales range XCOR II orders above $3.6M expected in Q2 sales

⚖️ Verdict: ⚪ Neutral

The story is unchanged, because the quarter's best news repeats the pattern behind the doubts: stores placing first orders for a new product. On the plus side, customers paid for May's shipments. The bad news: direct online sales held steady, so the drop came from stores, distributors and the hair-care brand.

The question now is whether shoppers buy the earbuds that stores hold. If they do, stores reorder and sales keep growing; if not, sales fall back once the launch orders ship. The third quarter, from December to February, will tell.

🐂 Bull Case

🟢🟢 strengthening PRODUCT

New XCOR II Earbuds Drew Early Store Orders

XCOR II is the new version of Axil's flagship line of wireless earbuds, its main earbud product. Chief executive Jeff Toghraie called its launch the "principal development of the quarter". Axil announced the earbuds on August 26, and orders passed $2.8 million that same day.

Shoppers could buy XCOR II from September 15. By September 30, orders came to more than $3.6 million "across retail, distribution, and direct-to-consumer", Toghraie said. He described it as "the strongest early demand we have seen for an AXIL product". Axil had also "fulfilled the majority of the XCOR II order backlog" by that date.

This matters because the old XCOR slowed before the new one arrived, and that gap cost sales this quarter. But orders are not yet sales. Axil warned that "order cancellations and returns" could reduce how much turns into revenue. Stores that stock a new product also fill shelves once, so first orders do not show what shoppers buy.

What to watch: second-quarter revenue, due in January, and how much of it came from XCOR II. A second quarter well above last year's would show that the orders became sales that stuck.

🟢 new CASH

Customers Paid, and Cash Reached $7.9 Million

Axil ended August with $7.9 million of cash and no borrowings, up from $4.5 million at the end of May. Most of the new cash came from stores and distributors paying for the large orders Axil shipped in May.

  • Money owed by customers: $1.3 million, down from $4.7 million at the end of May
  • Cash from operations: $3.8 million, against $0.7 million used a year ago

That answers part of a standing worry, because the move into big chains had tied up cash in unpaid bills. But a payment shows that a store bought the goods, not that shoppers did.

What to watch: money owed by customers at the end of November, after the XCOR II shipments. A large rise against sales would mean Axil again funds its stores.

🟢 persistent GROWTH

Positives this quarter didn't test

Two standing reasons for optimism got no clear reading this quarter. In both cases, the timing of the XCOR II launch pushed the test into the second quarter, which runs from September to November.

  • More stores: Axil gave no new store count and did not mention the Marine Corps Exchange launch. The next release should update both.
  • Costs as a share of sales: Axil paid for launch advertising now and books the launch sales next quarter. The second quarter is the first fair test.

🐻 Bear Case

🔴🔴 strengthening GROWTH contradicts narrative

Sales Fell Outside Axil's Own Online Store

Last year Axil moved from selling mostly through its own website to selling through big chains. The earbud maker blamed this quarter's drop in sales on the "planned transition from XCOR to XCOR II". It also cited a large store order from a year ago that did not repeat.

Those reasons leave out where the drop happened. Direct online sales of hearing products fell less than 1%, Axil said. So the lost sales came from stores, distributors and Reviv3, the hair and skin care brand.

  • Revenue against the previous quarter: down 29%
  • Stores carrying Axil: about 6,000 at the end of May, against about 1,800 a year earlier

The numbers cut against Axil's explanation. About three times as many stores carry its products as a year ago, yet sales outside its website fell. A launch gap explains part of that. But if chains had sold through May's shipments, their reorders of other models would have filled more of it.

What to watch: third-quarter revenue, reported in April, once launch orders are behind it. Sales near this level would mean May's shipments filled shelves rather than started regular reorders.

🔴🔴 new MARGIN

Without the Duty Refund, Operations Lost Money

Axil earned $437,000 from operations in the quarter. That figure includes a one-time refund of import duties that cut product costs by $0.55 million. By our math, the business lost about $113,000 from operations without the refund.

"Underlying margin was 73.6 percent, in line with our history," chief executive Jeff Toghraie said. It is above each of the previous four quarters. By our math, product costs fell 6.0 percentage points of revenue without the refund. So the cost of making the products did not cause the loss.

  • Sales and marketing: 46.6% of revenue, up 6.3 percentage points
  • Research and development: 7.5% of revenue, a new line that was zero a year ago
  • Launch advertising for XCOR II: about $360,000

Spending caused the loss. Launch advertising explains most of the sales and marketing rise, because without it that line would have stayed near 41% of revenue by our math. The release gives no reason for the research spending.

What to watch: research and development spending in the second quarter. If it stays near this level while sales recover, Axil has added a lasting cost that the launch does not explain.

🔴 persistent CASH

Inventory Stayed High While Sales Fell

Inventory, the finished products Axil holds before selling them, stayed at $4.4 million at the end of August, about the same as in May. Sales fell over that time.

Axil said the quarter included "inventory staging related to XCOR II launch". The refund also cut the recorded cost of unsold goods by $0.32 million. By our math, inventory rose 22% from a year ago without it.

New XCOR II stock explains part of it, but the first XCOR slowed. Inventory now equals 73% of a quarter's sales, against 57% a year ago, so Axil may hold old earbuds that sell slowly.

What to watch: inventory at the end of November, after most XCOR II orders shipped. A similar level would mean more stock than the launch explains.

🔴 persistent GOVERNANCE

Risks this quarter didn't answer

Several standing risks got no new figures in the press release. The quarterly filing or the next release would settle most of them, and each item below names the reading that would move it.

  • Related-party loans: advances fell to $56,000 from $1.2 million a year ago. The filing will show fees to firms linked to executives.
  • One large customer: the filing's customer note will show whether last year's biggest chain reordered after May.
  • New US tariffs: duties on goods from Axil's main overseas supplier started in July; second-quarter gross margin will show their cost.
  • XCOR II orders: buyers can still cancel or return them; second-quarter revenue will show how many held.
  • No sales forecast: Axil again gave no numeric sales range, so results can swing from quarter to quarter.

👓 Other Themes

new CAPITAL ALLOCATION

Partners Took a Quarter of Reviv3

Axil brought three partners into Reviv3, its hair and skin care brand, "to lead the planned global relaunch". The partners received about 25% of Reviv3 for their services, and Axil kept 75% and control. Axil booked the stake as a $137,511 non-cash expense. By our math, that puts a value of about $550,000 on all of Reviv3.

persistent MACRO

Import Duty Refunds Are Now Complete

US customs paid Axil $0.9 million, including interest, to refund import duties charged under IEEPA, an emergency-powers law. Axil split the money between this quarter's product costs, unsold stock and interest income. The company said it has no refund claims left, so this boost to margins ends here.

💲 Other KPIs

Prepaid warranties and service (contract liabilities), 27Q1 $378,801
⇘ decelerating

Fell again. Contract liabilities, mostly extended warranties that customers paid for but Axil has not yet earned, dropped to $378,801. That is 23% below May and 59% below a year ago, a fourth straight fall. The stream comes with direct online sales, so it shrinks as sales shift to stores.

Diluted share count, 27Q1 8.25 million
⇒ stable

Barely moved. The diluted share count, which includes preferred shares that can convert to common stock, rose 0.1% from a year ago. It has stayed between 8.2 and 8.3 million for five quarters, because the hearing-products maker neither bought back stock nor issued much new stock.

Capital spending, 27Q1 $165,213
⇗ accelerating

Rose. Spending on equipment and intangible assets grew 75% from a year ago. It equals 2.7% of revenue, against 1.4% a year earlier. The amounts stay small, so they do not strain the balance sheet.

🔮 Guidance

Q2 revenue from XCOR II orders Orders above $3.6 million expected to turn into Q2 revenue; no range given
⇗ accelerating

New. Axil expects the XCOR II orders and launch advertising to show up in second-quarter sales, but it gave no sales range. By our math, the orders equal 59% of first-quarter revenue. A year ago, sales rose 19% from the first quarter to the second, so the season also helps. The release gave no full-year outlook.

❓ Key Questions

Did the largest store customer reorder after May?

One chain bought about a quarter of Axil's hearing products last year. Its reorders show whether May's big shipments sold to shoppers or still sit on shelves.

How many stores carry Axil products now?

Axil gave no store count this quarter and did not update the Marine Corps Exchange launch. The count is the clearest measure of the store strategy.

What does the new research spending pay for?

Research and development became a sizeable cost line this quarter. Investors need to know whether it is one-time launch work or a lasting cost.

Who are the three new Reviv3 partners?

Axil did not name the partners or say what services they provide. Readers need both to judge whether the value placed on their stake is fair.

How many XCOR II orders can stores still return?

Axil warned that cancellations and returns could cut how much of the orders becomes revenue. Store return rights decide how firm second-quarter sales are.